These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
178 related articles for article (PubMed ID: 11326092)
1. Dominant-negative mutants of a toxin subunit: an approach to therapy of anthrax. Sellman BR; Mourez M; Collier RJ Science; 2001 Apr; 292(5517):695-7. PubMed ID: 11326092 [TBL] [Abstract][Full Text] [Related]
2. A soluble receptor decoy protects rats against anthrax lethal toxin challenge. Scobie HM; Thomas D; Marlett JM; Destito G; Wigelsworth DJ; Collier RJ; Young JA; Manchester M J Infect Dis; 2005 Sep; 192(6):1047-51. PubMed ID: 16107958 [TBL] [Abstract][Full Text] [Related]
3. Designing a polyvalent inhibitor of anthrax toxin. Mourez M; Kane RS; Mogridge J; Metallo S; Deschatelets P; Sellman BR; Whitesides GM; Collier RJ Nat Biotechnol; 2001 Oct; 19(10):958-61. PubMed ID: 11581662 [TBL] [Abstract][Full Text] [Related]
11. A dominant negative mutant of Bacillus anthracis protective antigen inhibits anthrax toxin action in vivo. Singh Y; Khanna H; Chopra AP; Mehra V J Biol Chem; 2001 Jun; 276(25):22090-4. PubMed ID: 11278644 [TBL] [Abstract][Full Text] [Related]
12. The LDL receptor-related protein LRP6 mediates internalization and lethality of anthrax toxin. Wei W; Lu Q; Chaudry GJ; Leppla SH; Cohen SN Cell; 2006 Mar; 124(6):1141-54. PubMed ID: 16564009 [TBL] [Abstract][Full Text] [Related]
13. Where and how do anthrax toxins exit endosomes to intoxicate host cells? Puhar A; Montecucco C Trends Microbiol; 2007 Nov; 15(11):477-82. PubMed ID: 17983750 [TBL] [Abstract][Full Text] [Related]
14. Anthrax protective antigen: efficiency of translocation is independent of the number of ligands bound to the prepore. Zhang S; Cunningham K; Collier RJ Biochemistry; 2004 May; 43(20):6339-43. PubMed ID: 15147218 [TBL] [Abstract][Full Text] [Related]
15. Fusion protein of Delta 27LFn and EFn has the potential as a novel anthrax toxin inhibitor. Kong Y; Guo Q; Yu C; Dong D; Zhao J; Cai C; Hou L; Song X; Fu L; Xu J; Chen W FEBS Lett; 2009 Apr; 583(8):1257-60. PubMed ID: 19332063 [TBL] [Abstract][Full Text] [Related]
16. Identification of the cellular receptor for anthrax toxin. Bradley KA; Mogridge J; Mourez M; Collier RJ; Young JA Nature; 2001 Nov; 414(6860):225-9. PubMed ID: 11700562 [TBL] [Abstract][Full Text] [Related]
17. Effects of dynamin inactivation on pathways of anthrax toxin uptake. Boll W; Ehrlich M; Collier RJ; Kirchhausen T Eur J Cell Biol; 2004 Jul; 83(6):281-8. PubMed ID: 15511085 [TBL] [Abstract][Full Text] [Related]
18. Mapping dominant-negative mutations of anthrax protective antigen by scanning mutagenesis. Mourez M; Yan M; Lacy DB; Dillon L; Bentsen L; Marpoe A; Maurin C; Hotze E; Wigelsworth D; Pimental RA; Ballard JD; Collier RJ; Tweten RK Proc Natl Acad Sci U S A; 2003 Nov; 100(24):13803-8. PubMed ID: 14623961 [TBL] [Abstract][Full Text] [Related]
19. Involvement of domain 3 in oligomerization by the protective antigen moiety of anthrax toxin. Mogridge J; Mourez M; Collier RJ J Bacteriol; 2001 Mar; 183(6):2111-6. PubMed ID: 11222612 [TBL] [Abstract][Full Text] [Related]
20. Deletion mutants of protective antigen that inhibit anthrax toxin both in vitro and in vivo. Ahuja N; Kumar P; Alam S; Gupta M; Bhatnagar R Biochem Biophys Res Commun; 2003 Aug; 307(3):446-50. PubMed ID: 12893241 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]